Prana Company Profile
3275 Corporate View
United States of America
(Reuters) - Prana Biotechnology Ltd said its experimental drug to treat a hereditary degenerative brain disorder met the main goals of safety and tolerability in a mid-stage study, sending Prana...
Prana Biotechnology Ltd. (ASX:PBT; NASDAQ:PRAN) fell on NASDAQ on Monday after the company reported that PBT2 missed the primary endpoint of reducing beta amyloid plaque levels at one year vs. placebo...
H.C. Wainwright has initiated coverage of Prana Biotechnology (NASDAQ:PRAN; ASX:PBT) with a “buy” rating at one-year price target of $20.50. The ADRs closed at $7.25 on Monday. “In our view, two...
Prana Biotechnology released the top-line results of the 12-month Phase 2 imaging trial in Alzheimer’s disease (IMAGINE Trial), based on draft results. Prana’s PBT2 did not meet its pri
H.C. Wainwright has raised its price target for “buy-rated” Prana Biotechnology (NASDAQ:PRAN; ASX:PBT) to $33 from $20.50 after the company reported positive results from a Phase 2a Reach2HD trial...
Prana Biotechnology announced the results of its Reach2HD Phase 2 clinical trial investigating PBT2 as a treatment for Huntington's disease.
Shares of Prana Biotechnology Ltd. shed most of their value Monday before markets opened and after the Australian drug developer said its most advanced potential treatment missed the main goal in a st...
SYDNEY, Feb 19 (Reuters) - Australia's Prana Biotechnology Ltd shares jumped as much as 26 percent on Wednesday, after the company said its experimental brain disorder drug improved cognitive function...
Drugs and Medications
Prana Biotechnology was established to commercialise research into Alzheimer's disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the A...
Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease...
More Information about "Prana" on BioPortfolio
We have published hundreds of Prana news stories on BioPortfolio along with dozens of Prana Clinical Trials and PubMed Articles about Prana for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prana Companies in our database. You can also find out about relevant Prana Drugs and Medications on this site too.